-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 14, German specialty chemicals manufacturer Lanxess announced that it had signed an agreement to acquire Emerald Kalama Chemical, a U.
S.
peer, with an enterprise value of $1.
08 billion
.
In fact, back in November 2020, Lanxess CEO Matthias Zachert said on an earnings call in November that the company had as much as 2 billion euros ($2.
4 billion) in funding to pursue deals, and Emerald Kalama would In line with its interest in higher-margin specialty chemical assets
.
The goal is to increase sales to the consumer market, Zachert told stock analysts on a conference call this time around
.
On the conference call, Zachert acknowledged that benzoic acid is a commodity that Chinese companies are increasingly producing
.
Matthias Zachert also said: "Emerald Kalama Chemical's business is a perfect fit for us
.